
Teleflex (TFX) Stock Forecast & Price Target
Teleflex (TFX) Analyst Ratings
Bulls say
Teleflex is a company that is facing temporary challenges with the integration of Biotronik, but still demonstrates strong earnings and growth. The recent changes in leadership and focus on growth and divestitures show a commitment to improving the company's performance. However, potential risks such as slower product adoption and macroeconomic challenges should be taken into consideration.
Bears say
Teleflex is facing integration challenges with the recent Biotronik acquisition, which could impact sales growth in the short term. The company is also planning to divest its Acute Care/Interventional business by 2026, but delays may result in a longer timeline to utilize proceeds for capital deployment. However, the company has a solid capital allocation strategy in place and potential upside to estimates and valuation in the future, making it a stock to monitor for long-term growth opportunities.
This aggregate rating is based on analysts' research of Teleflex and is not a guaranteed prediction by Public.com or investment advice.
Teleflex (TFX) Analyst Forecast & Price Prediction
Start investing in Teleflex (TFX)
Order type
Buy in
Order amount
Est. shares
0 shares